In order to develop models of recurrent IDH-mutant tumors, we cultured fresh tumor tissue at recurrence from 2 patients with prior TMZ treatment who were originally diagnosed with IDH1-mutant LGG. This evidence concerns the gene IDH2 and neoplasm.